NouLife: Synthesis of Linked Conjugates

In 2023, Innovotech acquired a 60% interest in NouLife Sciences Inc., a company that developed the intellectual property for the linking of two antioxidant molecules commonly used in skin care products – alpha lipoic acid and acetyl-L-carnitine – into one molecule. The linking of the two molecules has been indicated by NouLife to increase the […]

Read More
L2M- TATOM

We will validate TATOM (Tumor-on-a-chip assembly to observe metastasis), a miniature human-on-a-chip platform mimicking cancer metastasis for drug testing. Through customer discovery and market analysis by initially interviewing critical parties in the sector. Through these interviews, we will assess commercial viability, identify user needs, and finally refine the business model to accelerate translation to clinic […]

Read More
Applied AI Solution Development V2

This project aims to help Rogers Communications bring real-world AI and Generative AI (GenAI) solutions to life across Business units like Customer Care, Network, HR and Rogers Business. A team of five interns from the University of Waterloo will work with Rogers’ Data & AI Strategy team to turn identified promising use cases into working […]

Read More
L2M – Low-carbon modular concrete buildings

Housing shortage is one of the most serious societal issues that Canada is dealing with. On the other hand, the shrinking number of workforce is expected to increase the construction duration and cost of the new project. Furthermore, the influence of climate change in the form of wildfires and hurricanes threatens the conventional methods of […]

Read More
L2M Launch – Commercialization of Natural Polymer-Based Wound Dressings

In collaboration with the Lab2Market Launch program, our goal is to transition our natural polymer-based wound dressing from the lab bench to commercial scale. Designed specifically for individuals with chronic wounds and fragile skin conditions, our hydrogel-based dressing aims to fill a critical gap in the market. Through the program, we seek to deepen our […]

Read More
L2M – GradientX

Nowadays, many young Canadians [2] and newcomers [1] begin their financial journey with limited access to guidance on saving and investing, which leaves them at risk of debt and missed opportunities to build wealth. Existing tools are often complex and designed for experienced investors, not beginners. This project aims to develop and validate GradientX, an […]

Read More
L2M – SensRIM

For manual wheelchair users, mobility means pushing thousands of times each day, often leading to pain, fatigue, and upper-limb injuries. SensRIM is an innovative, sensor-integrated ergonomic pushrim designed to transform this daily effort into data-driven mobility, enhancing independence, comfort, and health outcomes. By embedding soft tactile sensors that directly measure propulsion forces and detect user […]

Read More
L2M – The Edge-Aware Diffusion for Contrast Enhancement

Artificial intelligence tools for contrast enhancement in medical imaging often improve visibility but may remove subtle structural details, reducing diagnostic reliability and clinical confidence. This project focuses on validating and preparing for the commercialization of the Edge-Aware Diffusion for Contrast Enhancement framework, which uses an edge-aware diffusion process to improve image contrast while preserving fine […]

Read More
L2M – InclusivAI: AI-powered Instructional Design Agent

This project focuses on validating InclusivAI, an AI-powered instructional design agent that helps faculty redesign courses for greater inclusivity and accessibility. Grounded in established frameworks for inclusive education and accessibility, InclusivAI applies AI to support evidence-informed course design and faculty development. Through the Mitacs Lab2Market Validate program, the project will analyze insights from faculty and […]

Read More
L2M Launch – Wonder Guard: An AI-Powered Catheter Sensor System to Detect and Predict Infection

Wonder Guard is an AI-powered catheter sensor system that is capable of detecting and predicting infection. We are developing an infection surveillance system using electrochemical DNA biosensors and AI-driven analytics to make assisted diagnoses. The device is a module add-on to existing hospital catheter systems that can continuously produce and analyze data to monitor UTIs, […]

Read More